Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction

被引:128
作者
Barber, Thomas M. [1 ,2 ]
Kyrou, Ioannis [1 ,2 ,3 ]
Randeva, Harpal S. [1 ,2 ,3 ]
Weickert, Martin O. [1 ,2 ,4 ]
机构
[1] Univ Hosp Coventry & Warwickshire, Warwickshire Inst Study Diabet Endocrinol & Metab, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England
[2] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry CV2 2DX, W Midlands, England
[3] Aston Univ, Coll Hlth & Life Sci, Aston Med Sch, Aston Med Res Inst, Birmingham B4 7ET, W Midlands, England
[4] Coventry Univ, Fac Hlth & Life Sci, Ctr Sport Exercise & Life Sci, Coventry CV1 5FB, W Midlands, England
关键词
insulin resistance; obesity; metabolic dysfunction; cognitive dysfunction; PULP PREPARATION RICH; TYPE-2; DIABETES-MELLITUS; INSOLUBLE DIETARY FIBER; CEREAL-FIBER; ALZHEIMERS-DISEASE; GLUCOSE-METABOLISM; OXIDATIVE STRESS; FASTING INSULIN; PROTEIN-CONTENT; GUT MICROBIOTA;
D O I
10.3390/ijms22020546
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity mediates most of its direct medical sequelae through the development of insulin resistance (IR). The cellular effects of insulin occur through two main postreceptor pathways that are the phosphatidylinositol 3-kinase (PI3-K) and the mitogen-activated protein kinase (MAP-K) pathways. Obesity-related IR implicates the PI3-K pathway that confers the metabolic effects of insulin. Numerous and complex pathogenic pathways link obesity with the development of IR, including chronic inflammation, mitochondrial dysfunction (with the associated production of reactive oxygen species and endoplasmic reticulum stress), gut microbiota dysbiosis and adipose extracellular matrix remodelling. IR itself plays a key role in the development of metabolic dysfunction, including hypertension, dyslipidaemia and dysglycaemia. Furthermore, IR promotes weight gain related to secondary hyperinsulinaemia, with a resulting vicious cycle of worsening IR and its metabolic sequelae. Ultimately, IR underlies obesity-related conditions such as type 2 diabetes mellitus (T2D) and polycystic ovary syndrome (PCOS). IR also underlies many obesity-related malignancies, through the effects of compensatory hyperinsulinaemia on the relatively intact MAP-K insulin pathway, which controls cellular growth processes and mitoses. Furthermore, the emergent data over recent decades support an important role of obesity- and T2D-related central IR in the development of cognitive dysfunction, including effects on hippocampal synaptic plasticity. Importantly, IR is largely reversible through the optimisation of lifestyle factors that include regular engagement in physical activity with the avoidance of sedentariness, improved diet including increased fibre intake and sleep sufficiency. IR lies at the key crossroad between obesity and both metabolic and cognitive dysfunction. Given the importance of IR in the pathogenesis of many 21st century chronic diseases and its eminent reversibility, it is important that we all embrace and facilitate optimised lifestyles to improve the future health and wellbeing of the populace.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 136 条
[1]   The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism [J].
Aftab, S. A. Saboor ;
Kumar, S. ;
Barber, T. M. .
CLINICAL ENDOCRINOLOGY, 2013, 78 (03) :330-337
[2]   Insulin receptor signaling in rat hippocampus: A study in STZ (ICV) induced memory deficit model [J].
Agrawal, Rahul ;
Tyagi, Ethika ;
Shukla, Rakesh ;
Nath, Chandishwar .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 (03) :261-273
[3]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[4]   How the association between obesity and inflammation may lead to insulin resistance and cancer [J].
Amin, Mohammad Nurul ;
Hussain, Md. Saddam ;
Sarwar, Md. Shahid ;
Moghal, Md. Mizanur Rahman ;
Das, Abhijit ;
Hossain, Mohammad Zahid ;
Chowdhury, Jakir Ahmed ;
Millat, Md. Shalahuddin ;
Islam, Mohammad Safiqul .
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (02) :1213-1224
[5]   Cognitive consequences of overweight and obesity in the ninth decade of life? [J].
Aslan, Anna K. Dahl ;
Starr, John M. ;
Pattie, Alison ;
Deary, Ian .
AGE AND AGEING, 2015, 44 (01) :59-65
[6]   Obesity and cancer risk: Emerging biological mechanisms and perspectives [J].
Avgerinos, Konstantinos, I ;
Spyrou, Nikolaos ;
Mantzoros, Christos S. ;
Dalamaga, Maria .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 92 :121-135
[7]   Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes [J].
Baker, Laura D. ;
Cross, Donna J. ;
Minoshima, Satoshi ;
Belongia, Dana ;
Watson, Stennis ;
Craft, Suzanne .
ARCHIVES OF NEUROLOGY, 2011, 68 (01) :51-57
[8]   Insulin resistance in obesity: an overview of fundamental alterations [J].
Barazzoni, Rocco ;
Cappellari, Gianluca Gortan ;
Ragni, Maurizio ;
Nisoli, Enzo .
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY, 2018, 23 (02) :149-157
[9]   Type 2 diabetes mellitus and Alzheimer's disease [J].
Barbagallo, Mario ;
Dominguez, Ligia J. .
WORLD JOURNAL OF DIABETES, 2014, 5 (06) :889-893
[10]   Obesity and polycystic ovary syndrome [J].
Barber, T. M. ;
McCarthy, M. I. ;
Wass, J. A. H. ;
Franks, S. .
CLINICAL ENDOCRINOLOGY, 2006, 65 (02) :137-145